CAS 14484-47-0
:Déflazacort
- (11β,16β)-11-hydroxy-2-methyl-5β-H-progna-1,4-dieno[17,16-d]Oxazolo-3,20-dione
- (11β,16β)-21-(Acetyloxy)-11-hydroxy-2′-methyl-5′H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
- (4Ar,4Bs,5S,6As,9Ar,10As,10Bs)-6B-Acetyl-5-Hydroxy-4A,6A,8-Trimethyl-4A,4B,5,6,6A,6B,9A,10,10A,10B,11,12-Dodecahydro-9-Oxa-7-Aza-Pentaleno[2,1-A]Phenanthren-2-One
- (4aR,4bS,5S,6aS,9aR,10aS,10bS)-6b-acetyl-5-hydroxy-4a,6a,8-trimethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-2-one
- 11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 21-acetate
- 2-(5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl)-2-oxoethyl acetate
- 2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl]-2-oxoethyl acetate
- 2H-Naphth[2′,1′:4,5]indeno[1,2-d]oxazole, 5′H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione deriv.
- 5′H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 21-(acetyloxy)-11-hydroxy-2′-methyl-, (11β,16β)-
- 5′β<span class="text-smallcaps">H</span>-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 11β,21-dihydroxy-2′-methyl-, 21-acetate
- Azacort
- Azacortinol
- Calcort
- Deflan
- Deflazacort Intermediate
- Dezacor
- Dezacort
- Dl 458It
- Emflaza
- Flantadin
- L 5458
- Lantadin
- Mdl 458
- Oxazacort
- Pregna-1,4-Diene-11B-Ol-17A,16A-D-2-Methyl-Oxazoline-3,20-Dione
- Deflazacort
- DEFLAZACORT
- Deflazacort intermediate(D5)
- Voir plus de synonymes
Deflazacort
CAS :Formule :C25H31NO6Degré de pureté :>98.0%(HPLC)(N)Couleur et forme :White to Almost white powder to crystalMasse moléculaire :441.52Deflazacort
CAS :Formule :C25H31NO6Couleur et forme :White To Off-White SolidMasse moléculaire :441.52GB/T 24800.2-2009 41 Glucocorticoids 100 µg/mL in Methanol
CAS :Produit contrôlé- 105102-22-5
- 1177-87-3
- 124-94-7
- 13609-67-1
- 14484-47-0
- 1524-88-5
- 2135-17-3
- 2152-44-5
- 25122-46-7
- 25122-57-0
- 3093-35-4
- 33564-31-7
- 356-12-7
- 378-44-9
- 3801-06-7
- 3870-07-3
- 426-13-1
- 4419-39-0
- 50-02-2
- 50-03-3
- 50-04-4
- 50-23-7
- 50-24-8
- 51022-69-6
- 51333-22-3
- 514-36-3
- 53-06-5
- 5534-09-8
- 5593-20-4
- 57524-89-7
- 66734-13-2
- 67-78-7
- 73771-04-7
- 76-25-5
- 80474-14-2
- 83-43-2
- 987-24-6
Couleur et forme :MixtureDeflazacort
CAS :Formule :C25H31NO6Degré de pureté :≥ 98.0%Couleur et forme :White to almost white powderMasse moléculaire :441.52Deflazacort
CAS :Produit contrôléApplications A systemic corticosteroid. A derivative of prednisolone. Used for rheumatoid arthritis and lupus.
References Nathansohn, G., et al.: J. Med. Chem., 10,799 (1967), Schiatti, P., et al.: Arzneim. Forsch., 30, 1543 (1980), Cavall-Perin, P., et al.: Eur. J. Clin. Pharmacol., 26, 357 (1984), Imbimbo, B., et al.: Adv. Exp. Med. Biol., 171, 241 (1984),Formule :C25H31NO6Couleur et forme :NeatMasse moléculaire :441.52Deflazacort-d3
CAS :Produit contrôléApplications Deflazacort-d3, is the labeled analogue of Deflazacort (D228975), a systemic corticosteroid, and a derivative of prednisolone. Used for rheumatoid arthritis and lupus.
References Nathansohn, G., et al.: J. Med. Chem., 10,799 (1967), Schiatti, P., et al.: Arzneim. Forsch., 30, 1543 (1980), Cavall-Perin, P., et al.: Eur. J. Clin. Pharmacol., 26, 357 (1984), Imbimbo, B., et al.: Adv. Exp. Med. Biol., 171, 241 (1984),Formule :C25H28D3NO6Couleur et forme :NeatMasse moléculaire :444.54Deflazacort
CAS :Produit contrôléDeflazacort is a corticosteroid used to treat chronic inflammatory diseases of the bowel and skin. It has been shown to inhibit the growth of human tumor xenografts in mice, although it is not active against bacteria or fungi. Deflazacort has also been shown to have an antimicrobial effect on human cells in culture. The mechanism of action is not known, but may be due to its ability to stimulate production of an antimicrobial protein called defensin. Deflazacort has also been shown to be effective in treating rheumatoid arthritis, lupus erythematosus, and other autoimmune diseases. Deflazacort has a side-effect profile that includes hypertension, hyperglycemia, hypokalemia, and gastrointestinal ulceration.Formule :C25H31NO6Degré de pureté :Min. 98 Area-%Couleur et forme :White PowderMasse moléculaire :441.52 g/mol21-Deacetoxy-21-dimethoxy Deflazacort
CAS :Produit contrôléFormule :C25H33NO6Couleur et forme :NeatMasse moléculaire :443.533Deflazacort-d3 (Major)
CAS :Produit contrôléFormule :C25H28D3NO6Couleur et forme :NeatMasse moléculaire :444.54







